Skip to main content
. Author manuscript; available in PMC: 2021 Aug 2.
Published in final edited form as: Circ Genom Precis Med. 2021 Mar 1:10.1161/CIRCGEN.120.003269. doi: 10.1161/CIRCGEN.120.003269

Table 1.

Characteristics of the study population

Characteristics Patients without atrial fibrillation (n=788) Patients with atrial fibrillation (n=259)
Age, years (median and IQR) 61.9 [53.8; 68.9] 71.2 [62.7 – 76.0]
Female sex 261 (33.1%) 79 (30.1%)
Year of surgery 2010 [2007; 2013] 2010 [2008; 2012]
Chronic obstructive pulmonary disease 116 (14.7%) 60 (23.2%)
Coronary artery bypass graft surgery 566 (71.8%) 178 (68.7%)
Heart valve surgery 292 (37.1%) 121 (46.7%)
Preoperative medication:
 Angiotensin-converting enzyme inhibitor use 105 (13.3%) 51 (19.7%)
 Beta-blocker use 620 (78.7%) 215 (83%)
 Nonsteroidal anti-inflammatory drug use 13 (1.6%) 11 (4.2%)
 Statin use 276 (35%) 92 (35.5%)

Continuous variables are presented as median [IQR, interquartile range], and frequency and percentage for the presentation of categorical variables.